Tandem Diabetes Care (TNDM) Operating Income (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Operating Income came in at -$17.4 million in Q1 2026, up 85.58% YoY from -$9.4 million in Q1 2025, and down 310.2% on a QoQ basis from $8.3 million in Q4 2025.
Tandem Diabetes Care (TNDM) Operating Income (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Operating Income data on file, last reported at -$17.4 million in Q1 2026.
- Quarterly Operating Income rose 85.58% year-over-year to -$17.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$83.8 million (up 53.0% YoY) and the FY2025 annual result came in at -$187.3 million, down 88.91% from the prior year.
- Operating Income declined to -$17.4 million in Q1 2026, from $8.3 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $8.3 million in Q4 2025 to a low of -$127.8 million in Q1 2023.
- A 5-year average of -$37.1 million and a median of -$30.8 million in 2024 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income sank 733.34% — and 2025, when it soared 1527.54%.
- Tracing TNDM's Operating Income over 5 years: stood at -$17.8 million in 2022, then plunged by 97.22% to -$35.1 million in 2023, then surged by 98.34% to -$581000.0 in 2024, then soared by 1527.54% to $8.3 million in 2025, then tumbled by 310.2% to -$17.4 million in 2026.
- The last three Operating Income figures came in at -$17.4 million (Q1 2026), $8.3 million (Q4 2025), and -$22.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | -13.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.79 Mn |
| Mar 31, 2026 | -17.43 Mn |
| Dec 31, 2025 | 8.29 Mn |
| Sep 30, 2025 | -22.86 Mn |
| Jun 30, 2025 | -51.81 Mn |
| Mar 31, 2025 | -120.88 Mn |
| Dec 31, 2024 | -581,000.00 |
| Sep 30, 2024 | -26.09 Mn |
| Jun 30, 2024 | -30.77 Mn |
| Mar 31, 2024 | -41.68 Mn |
| Dec 31, 2023 | -35.06 Mn |
| Sep 30, 2023 | -31.55 Mn |
| Jun 30, 2023 | -38.81 Mn |
| Mar 31, 2023 | -127.82 Mn |
| Dec 31, 2022 | -17.78 Mn |
| Sep 30, 2022 | -47.49 Mn |
| Jun 30, 2022 | -12.24 Mn |
| Mar 31, 2022 | -15.34 Mn |
| Dec 31, 2021 | 12.74 Mn |
| Sep 30, 2021 | 7.72 Mn |